SC 13G

Company

Protara Therapeutics, Inc.

Filed

February 21, 2020

Accession Number

0001193125-20-044333

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →